Norinchukin Bank, The Amgen Inc Transaction History

Norinchukin Bank, The

$4.18 Billion
Q3 2024

A detailed history of Norinchukin Bank, The transactions in Amgen Inc stock. As of the latest transaction made, Norinchukin Bank, The holds 37,458 shares of AMGN stock, worth $10.9 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

37,458

Previous 33,255 12.64%

Holding current value

$10.9 Million

Previous $10.4 Million 16.16%

% of portfolio

0.29%

Previous 0.3%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $1.3 Million - $1.42 Million	4,203 Added 12.64%	37,458 $12.1 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $105,100 - $127,724	-400 Reduced 1.19%	33,255 $10.4 Million
Q1 2024 May 14, 2024	SELL	$268.87 - $324.56 $873,020 - $1.05 Million	-3,247 Reduced 8.8%	33,655 $9.57 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $1.33 Million - $1.5 Million	-5,190 Reduced 12.33%	36,902 $10.6 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $9.2 Million - $11.4 Million	42,092 New	42,092 $11.3 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $2.16 Million - $2.55 Million	10,077 Added 16.87%	69,807 $15.5 Million
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $210,662 - $256,761	933 Added 1.59%	59,730 $14.4 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $2.47 Million - $3.14 Million	-10,801 Reduced 15.52%	58,797 $15.4 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $836,337 - $943,236	3,726 Added 5.66%	69,598 $15.7 Million
Q2 2022 Aug 10, 2022	SELL	$230.71 - $256.74 $3.92 Million - $4.36 Million	-16,999 Reduced 20.51%	65,872 $16 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $846,820 - $936,805	3,862 Added 4.89%	82,871 $20 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $1.25 Million - $1.43 Million	-6,295 Reduced 7.38%	79,009 $17.8 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $858,632 - $1.01 Million	4,045 Added 4.98%	85,304 $18.1 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $1.36 Million - $1.51 Million	5,822 Added 7.72%	81,259 $19.8 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $165,101 - $192,398	-744 Reduced 0.98%	75,437 $18.8 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $61,668 - $73,435	285 Added 0.38%	76,181 $17.5 Million
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $5.74 Million - $6.39 Million	24,477 Added 47.6%	75,896 $19.3 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $182,776 - $224,291	-924 Reduced 1.77%	51,419 $12.1 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $8.39 Million - $11.1 Million	-46,013 Reduced 46.78%	52,343 $10.6 Million
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $1.52 Million - $1.95 Million	-8,018 Reduced 7.54%	98,356 $23.7 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $78,871 - $94,504	453 Added 0.43%	106,374 $20.6 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $7.67 Million - $8.99 Million	-46,002 Reduced 30.28%	105,921 $19.5 Million
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $120,640 - $135,987	667 Added 0.44%	151,923 $28.9 Million
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $6.22 Million - $7.26 Million	34,865 Added 29.96%	151,256 $29.4 Million
Q3 2018 Nov 08, 2018	BUY	$185.29 - $208.89 $1.24 Million - $1.4 Million	6,696 Added 6.1%	116,391 $24.1 Million
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $1.39 Million - $1.56 Million	8,348 Added 8.24%	109,695 $20.2 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $1.05 Million - $1.23 Million	6,225 Added 6.54%	101,347 $17.3 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $596,672 - $666,665	3,535 Added 3.86%	95,122 $16.5 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $15.3 Million - $17.5 Million	91,587	91,587 $17.1 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.

Account

Norinchukin Bank, The Amgen Inc Transaction History